loading
전일 마감가:
$15.23
열려 있는:
$15.37
하루 거래량:
2.74M
Relative Volume:
1.77
시가총액:
$2.26B
수익:
$340.81M
순이익/손실:
$-419.65M
주가수익비율:
-5.4351
EPS:
-2.85
순현금흐름:
$-402.10M
1주 성능:
+5.37%
1개월 성능:
+11.68%
6개월 성능:
-25.28%
1년 성능:
-35.16%
1일 변동 폭
Value
$15.31
$16.19
1주일 범위
Value
$14.15
$16.19
52주 변동 폭
Value
$10.57
$33.33

Denali Therapeutics Inc Stock (DNLI) Company Profile

Name
명칭
Denali Therapeutics Inc
Name
전화
(650) 866-8547
Name
주소
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
Name
직원
486
Name
트위터
Name
다음 수익 날짜
2025-08-08
Name
최신 SEC 제출 서류
Name
DNLI's Discussions on Twitter

DNLI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
DNLI
Denali Therapeutics Inc
15.49 2.17B 340.81M -419.65M -402.10M -2.85
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-10 업그레이드 Cantor Fitzgerald Neutral → Overweight
2025-03-07 재개 Morgan Stanley Overweight
2025-02-11 개시 Deutsche Bank Buy
2025-01-07 개시 Robert W. Baird Outperform
2025-01-03 개시 William Blair Outperform
2024-12-16 업그레이드 Stifel Hold → Buy
2024-10-10 재개 Raymond James Mkt Perform
2024-10-07 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2023-12-13 개시 Citigroup Buy
2023-11-20 재개 JP Morgan Overweight
2023-10-24 재개 Cantor Fitzgerald Overweight
2023-09-06 개시 B. Riley Securities Buy
2023-01-30 개시 SVB Securities Outperform
2022-12-05 개시 Cowen Outperform
2022-11-02 업그레이드 BTIG Research Neutral → Buy
2022-11-02 개시 BofA Securities Buy
2022-06-23 개시 Berenberg Buy
2021-12-10 재개 Raymond James Mkt Perform
2021-09-21 개시 Oppenheimer Outperform
2021-09-01 개시 SMBC Nikko Outperform
2021-05-18 개시 UBS Buy
2021-02-26 재확인 H.C. Wainwright Buy
2021-02-10 업그레이드 Cantor Fitzgerald Neutral → Overweight
2020-11-11 재확인 H.C. Wainwright Buy
2020-10-16 다운그레이드 BTIG Research Buy → Neutral
2020-09-14 재개 JP Morgan Overweight
2020-08-20 재확인 H.C. Wainwright Buy
2020-03-13 업그레이드 Evercore ISI In-line → Outperform
2020-02-28 업그레이드 Wedbush Neutral → Outperform
2020-02-24 개시 Jefferies Buy
2020-02-19 개시 Stifel Hold
2020-01-27 업그레이드 Goldman Neutral → Buy
2019-09-26 개시 Wedbush Neutral
2019-09-13 개시 Nomura Buy
2019-08-09 개시 BTIG Research Buy
2019-06-26 개시 H.C. Wainwright Buy
2018-11-15 개시 Cantor Fitzgerald Overweight
2018-11-12 개시 Janney Buy
2018-03-12 다운그레이드 Evercore ISI Outperform → In-line
2018-01-02 개시 Evercore ISI Outperform
2018-01-02 개시 Goldman Neutral
2018-01-02 개시 JP Morgan Overweight
2018-01-02 개시 Morgan Stanley Overweight
모두보기

Denali Therapeutics Inc 주식(DNLI)의 최신 뉴스

pulisher
Aug 20, 2025

Denali Therapeutics Inc. (DNLI) Secures FDA Priority Review for First-Ever Brain-Penetrant Hunter Syndrome Therapy - MSN

Aug 20, 2025
pulisher
Aug 20, 2025

Can Denali Therapeutics Inc. Regain Lost Ground This Quarter2025 Price Targets & Smart Swing Trading Alerts - newsyoung.net

Aug 20, 2025
pulisher
Aug 16, 2025

Can Denali Therapeutics Inc. be the next market leaderEarnings Risk Report & Safe Capital Growth Tips - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Is Denali Therapeutics Inc. stock technically oversold2025 EndofYear Setup & Low Drawdown Trading Techniques - sundaytimes.kr

Aug 16, 2025
pulisher
Aug 16, 2025

BTIG Reiterates a Buy Rating on Denali Therapeutics (DNLI) With a $32 Price Target - MSN

Aug 16, 2025
pulisher
Aug 15, 2025

Why Denali Therapeutics Shares Are Slipping - TipRanks

Aug 15, 2025
pulisher
Aug 15, 2025

Is Denali Therapeutics Inc. subject to activist investor interestTrade Volume Report & AI Optimized Trade Strategies - thegnnews.com

Aug 15, 2025
pulisher
Aug 14, 2025

Denali Therapeutics Inc. Stock Approaches Key Moving Average2025 Valuation Update & Community Verified Swing Trade Signals - sundaytimes.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Denali Therapeutics COFO Schuth sells $39884 in stock By Investing.com - Investing.com Canada

Aug 14, 2025
pulisher
Aug 14, 2025

DNLI Tops on Q2 Earnings, Expects Decree on Hunter Syndrome Drug in '26 - MSN

Aug 14, 2025
pulisher
Aug 14, 2025

Denali therapeutics’ Ho Carole sells $52k in stock - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

Denali Therapeutics COFO Schuth sells $39884 in stock - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

Science Spotlight: How Denali’s CNS-penetrant amyloid mAb may avoid ARIA - BioCentury

Aug 14, 2025
pulisher
Aug 14, 2025

XTX Topco Ltd Lowers Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - Defense World

Aug 14, 2025
pulisher
Aug 14, 2025

Elliott Wave Theory Predicts Pullback in Denali Therapeutics Inc.July 2025 Reactions & Community Consensus Picks - beatles.ru

Aug 14, 2025
pulisher
Aug 14, 2025

Is now a turning point for Denali Therapeutics Inc.July 2025 Big Picture & Safe Entry Momentum Stock Tips - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

What makes Denali Therapeutics Inc. stock price move sharplyJuly 2025 Earnings & Smart Investment Allocation Insights - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings visualization tools for Denali Therapeutics Inc.Weekly Profit Summary & Weekly Momentum Picks - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Technical signs of recovery in Denali Therapeutics Inc.Dividend Hike & Weekly Consistent Profit Watchlists - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Denali Soars 11% on Biotech Sector Turmoil: What’s Fueling This Surge? - AInvest

Aug 13, 2025
pulisher
Aug 12, 2025

Using data filters to optimize entry into Denali Therapeutics Inc.Stock Trading Session Highlights and Summary - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Denali Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowSummary of Consistent Growth Stock Picks - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Denali Therapeutics shares fall 3.52% intraday after reporting mixed Q2 2025 results and regulatory updates. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

H.C. Wainwright Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $32 - 富途牛牛

Aug 12, 2025
pulisher
Aug 12, 2025

Denali Therapeutics: Advancements in CNS Delivery and Strategic Market Positioning Drive Buy Rating - TipRanks

Aug 12, 2025
pulisher
Aug 12, 2025

Denali Therapeutics: Promising Developments and Regulatory Momentum Drive Buy Rating - TipRanks

Aug 12, 2025
pulisher
Aug 12, 2025

Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times

Aug 12, 2025
pulisher
Aug 11, 2025

Denali Therapeutics reports Q2 EPS (72c), consensus (74c) - TipRanks

Aug 11, 2025
pulisher
Aug 11, 2025

Denali Therapeutics: Promising Pipeline and Regulatory Progress Justify Buy Rating - TipRanks

Aug 11, 2025
pulisher
Aug 11, 2025

Denali Therapeutics Inc. SEC 10-Q Report - TradingView

Aug 11, 2025
pulisher
Aug 11, 2025

Denali Therapeutics Q2 2025 Financial Results and Business Highlights: Tividenofusp Alfa BLA Accepted for Priority Review, DNL126 Accelerated Approval Path Aligned, and More. - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

FDA Fast-Tracks Denali's Breakthrough Hunter Syndrome Drug as Pipeline Expands - Stock Titan

Aug 11, 2025
pulisher
Aug 10, 2025

Possible Bearish Signals With Denali Therapeutics Insiders Disposing Stock - 富途牛牛

Aug 10, 2025
pulisher
Aug 07, 2025

BTIG Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $32 - 富途牛牛

Aug 07, 2025
pulisher
Aug 06, 2025

Denali Therapeutics (DNLI) to Release Quarterly Earnings on Thursday - Defense World

Aug 06, 2025
pulisher
Aug 05, 2025

Catalyst Pharmaceutics to Report Q2 Earnings: What's in the Cards? - The Globe and Mail

Aug 05, 2025
pulisher
Aug 04, 2025

Is Denali Therapeutics Inc. a good long term investmentMaster stock selection with insider knowledge - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

How strong is Denali Therapeutics Inc. company’s balance sheetCapitalize on momentum stocks before they peak - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are Denali Therapeutics Inc. company’s key revenue driversInvest smarter with daily market updates - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Denali Therapeutics Inc. stockFree Technical Analysis Support - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is Denali Therapeutics Inc. company’s growth strategyConsistent triple-digit returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Denali Therapeutics Inc. stock overvalued or undervaluedAchieve unparalleled market performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Denali Therapeutics Inc. stock perform well during market downturnsMaximize gains with expert trading strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Denali Therapeutics Inc. generate profit in a changing economyMarket-leading profit generation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Backtesting results for Denali Therapeutics Inc. trading strategiesForecast Model for Intraday Buy Signals - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Denali Therapeutics Inc. stock compared to the marketFree Daily Trading Room Entry - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What is the risk reward ratio of investing in Denali Therapeutics Inc. stockSky-high return potential - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is Denali Therapeutics Inc. a growth stock or a value stockAccelerated financial growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are analysts’ price targets for Denali Therapeutics Inc. in the next 12 monthsInvest smarter with cutting-edge analytics - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is it the right time to buy Denali Therapeutics Inc. stockTransform your portfolio with high-yield stocks - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation - MSN

Aug 02, 2025

Denali Therapeutics Inc (DNLI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Denali Therapeutics Inc 주식 (DNLI) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Ho Carole
Chief Medical Officer
Aug 12 '25
Sale
13.58
2,937
39,884
217,391
Ho Carole
Chief Medical Officer
Aug 13 '25
Sale
14.64
806
11,800
216,585
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
자본화:     |  볼륨(24시간):